Katie Osborne/The Pharmaceutical Journal
The managing director of Celesio UK, the parent company of LloydsPharmacy, has resigned with immediate effect, it has been announced.
Cormac Tobin has been with the group, which is the leading provider of integrated healthcare services to the NHS, for ten years. He was appointed managing director in early 2013.
The news comes a week after it was announced that 190 LloydsPharmacy stores in England would close or be sold off because they are no longer considered “commercially viable.”
Brian Tyler, chairman of the management board of McKesson Europe, of which Celesio is a part, says: “Cormac has been an energetic and trusted leader of our UK and Ireland businesses. He has built a strong leadership team for Celesio UK and his warm and engaging personality made him many friends across community pharmacy and beyond. There is a genuine affection for him among our colleagues who value his ability to understand customers and patients and put them at the heart of everything we do.
“I am grateful for the dedication that Cormac has shown over the last few years and his leadership through an ever-changing external environment. I wish him every success for the future.”
It was reported in June 2017 that Celesio UK’s earnings before interest and taxes for its continuing operations fell by 29.1% to £265.8m between April 2016 and March 2017 compared with the same period the previous year.
The Celesio UK Board will manage the business until a successor is found, Tyler added.
